test header

Immunology

EULAR

Barcelona

Poster

Differential pharmacodynamic changes of circulated immune subsets after treatment with abatacept or adalimumab POS0674 in patients with anticitrullinated protein antibody-positive early rheumatoid arthritis in the AMPLIFIED study

Nathanial Eddy, Jane Buckner, Paul Emery, Michael E. Weinblatt, Vivian P. Bykerk, Andrew P. Cope, Gerd R. Burmester, Yoshiya Tanaka, Gustavo Citera, Peter Nash, Quentin Dornic, Peter Schafer, Sheila Kelly, Michael A. Maldonado, Jinqi Liu.

Poster

In vitro and in vivo evidence of the steroid-sparing potential of afi metoran, an equipotent toll-like receptor 7/8 dual antagonist

Shailesh Dudhgaonkar, Siva Subramani, Puneet Chopra, Anjuman Rudra, Sourabha Palachandra, Nikita Sanjay Bhatt, Veeresh Pabbala, Sabariya Selvam, Mobeen Shaik, Amit Anand, Benjamin King, Kristina Chadwick, Alaric Dyckman, Qihong Zhao, Frédéric Baribaud, Ramya Janardana, Vineeta Shobha.

Poster

Understanding disease progression in patients with Sjögren’s Disease: Insights from the United Kingdom Primary Sjögren's Syndrome Registry

WF Ng, C Collins, A Christodoulou, K Mirchandani, M Sharma, J Cook, K Johannesen, B Becker, JC Choi.

Poster

Tolerability and efficacy of BMS-986353 (CC-97540), a CD19-directed chimeric antigen receptor T cell therapy manufactured using a next-generation process for systemic sclerosis: updated data from the phase 1 Breakfree-1 study

Dinesh Khanna, Margrit Wiesendanger, Richard Nash, Philip Mease, Anca Askanase, Elana Bernstein, Neil Kramer, Vikas Majithia, Jacques Azzi, David Korman, Krish Patel, Matthew H. Schwede, Ran Reshef, Ernesto Ayala, Alisha Desai, Griff McTume, Sharmila Das, Jerill Thorpe, Ashley Koegel, Georg Schett.

Poster

TYK2 Inhibition Suppresses Neutrophil Activation and NETosis in Spondyloarthritis: Insights from Animal Models and Human Samples

M. Katsushima, H. Sun, Y. Fujisawa, K. Fukumoto, R. Watanabe, S. Yamada, K. Habiro, N. Sugiyama, M. Hashimoto
Osaka Metropolitan University Graduate School of Medicine, Department of Clinical Immunology, Osaka, Japan
Bristol Myers Squibb.